AHR 10037

Drug Profile

AHR 10037

Latest Information Update: 14 Jul 1995

Price : $50

At a glance

  • Originator AH Robins
  • Class Analgesics; Antipyretics; Antirheumatics; Nonsteroidal anti-inflammatories
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Inflammation; Pain

Most Recent Events

  • 14 Jul 1995 Pain has been added to the defined services.
  • 20 Feb 1995 Discontinued-Preclinical for Pain in USA (Unknown route)
  • 20 Feb 1995 Discontinued-Preclinical for Inflammation in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top